Загрузка...

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors

BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kruser, Tim J., Wheeler, Deric L., Armstrong, Eric A., Iida, Mari, Kozak, Kevin R., van der Kogel, Albert J., Bussink, Johan, Coxon, Angela, Polverino, Anthony, Harari, Paul M.
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/
https://ncbi.nlm.nih.gov/pubmed/20507929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!